National Health Investors (NYSE:NHI) Receiving Somewhat Favorable Press Coverage, Report Finds

Press coverage about National Health Investors (NYSE:NHI) has trended somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. National Health Investors earned a news sentiment score of 0.22 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 46.4960586956327 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of brokerages recently weighed in on NHI. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday. Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Wednesday. ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Mizuho reiterated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Finally, Stifel Nicolaus boosted their price target on shares of National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. National Health Investors currently has an average rating of “Hold” and an average price target of $79.60.

Shares of National Health Investors (NYSE:NHI) traded up 0.34% during midday trading on Friday, reaching $76.54. 419,689 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $77.38 and its 200 day moving average price is $75.03. The firm has a market capitalization of $3.14 billion, a P/E ratio of 19.66 and a beta of 0.56. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. During the same period in the previous year, the company posted $1.22 EPS. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. On average, equities research analysts anticipate that National Health Investors will post $3.79 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 annualized dividend and a yield of 4.96%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is 97.69%.

TRADEMARK VIOLATION WARNING: This report was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.com-unik.info/2017/08/12/national-health-investors-nysenhi-receiving-somewhat-favorable-press-coverage-report-finds.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

What are top analysts saying about National Health Investors Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for National Health Investors Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit